Related Experiment Video
Updated: Jul 24, 2026
09:36
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Published on: August 29, 2018
10.3K
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
Nadin Rabah1, Fatima-Ezzahra Ait Mohand1, Nataly Kravchenko-Balasha1
1The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
International Journal of Molecular Sciences
|September 28, 2023
Summary
Glioblastoma (GBM) is a deadly brain cancer due to its heterogeneity and spread. Targeting these features and improving drug delivery could enhance GBM treatment and prevent recurrence.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Computational Biology
Background:
- Glioblastoma (GBM) is the most common and aggressive brain cancer.
- GBM is characterized by significant intra- and inter-tumor heterogeneity and invasive growth.
- Current treatments for GBM are largely ineffective due to tumor recurrence and resistance.
Purpose of the Study:
- To review the challenges in treating glioblastoma (GBM).
- To explore the role of tumor heterogeneity and spread in GBM recurrence.
- To discuss potential therapeutic strategies and the impact of the blood-brain barrier (BBB).
Main Methods:
- Literature review focusing on GBM heterogeneity, infiltration, and computational modeling.
- Analysis of factors contributing to drug resistance.
- Discussion of therapeutic difficulties and potential approaches.
Main Results:
- Tumor heterogeneity and diffusive nature are key drivers of GBM recurrence.
- The blood-brain barrier (BBB) impedes effective drug delivery to GBM tumors.
- Signaling heterogeneity, tumor infiltration, and computational modeling are critical areas for research.
Conclusions:
- Monitoring GBM heterogeneity and spread may provide novel therapeutic targets.
- Overcoming drug delivery challenges is crucial for effective GBM treatment.
- Further research into computational modeling and targeted therapies is needed to improve GBM patient outcomes.
Related Concept Videos
01:09Cell Migration
Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:26Signal Transduction: Overview
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...